Jacqueline Claire Lupo
Algemeen Directeur bij LOPHOS HOLDINGS INC.
Vermogen: 660 000 $ op 30-04-2024
Actieve functies van Jacqueline Claire Lupo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| LOPHOS HOLDINGS INC. | Directeur/Bestuurslid | 23-12-2021 | - |
| Algemeen Directeur | 23-12-2021 | - | |
Lophos Pharmaceuticals Corp.
 Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Directeur/Bestuurslid | 01-01-2021 | - |
| Algemeen Directeur | 01-09-2021 | - | |
| Oprichter | 01-01-2021 | - | |
| President | 01-09-2021 | - | |
| Northern Green Canada, Inc. | Corporate Officer/Principal | - | - |
Loopbaan van Jacqueline Claire Lupo
Eerdere bekende functies van Jacqueline Claire Lupo
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Canalytica Corp. | Oprichter | - | - |
Statistieken
Internationaal
| Canada | 5 |
Operationeel
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectoraal
| Process Industries | 2 |
| Health Technology | 2 |
| Consumer Non-Durables | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LOPHOS HOLDINGS INC. | Process Industries |
| Bedrijven in privébezit | 3 |
|---|---|
Lophos Pharmaceuticals Corp.
Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Health Technology |
| Northern Green Canada, Inc. | Consumer Non-Durables |
| Canalytica Corp. |
